New partnership established to track drugs using blockchain
Walmart has joined a consortium that’s attempting to build a blockchain for tracking pharmaceutical supply chains.
List view / Grid view
Walmart has joined a consortium that’s attempting to build a blockchain for tracking pharmaceutical supply chains.
Global active pharmaceutical ingredients market set to surpass US$274.9 billion by 2026.
The US Food and Drug Administration (FDA) has approved Piqray (alpelisib) tablets to treat patients with breast cancer.
With the UK bracing itself for a 'no-deal' Brexit or some other outcome that has not yet been determined, pharma experts discussed the potential effect of Brexit on the supply chain and how to best prepare for it against the upcoming deadline.
Shortages of inexpensive, essential medicines: calling for tangible political commitments in the EU...
Blockchain technologies have the potential to improve transparency, efficiency and reliability of transactions in a heavily regulated pharmaceutical industry. However, there are challenges and limitations. Nikki Withers speaks to Bob Celeste, founder of the Centre for Supply Chain Studies, who has been exploring the potential use of blockchain technology to…
Andrew Meyers has travelled across many countries designing, auditing, investigating and correcting failures in temperature supply chains. In this article he explores some examples of his observations from the field.
The pilot project will test innovative and emerging approaches for enhanced tracing and verification of prescription drugs in the US...
Service expansion in Brazil will meet transportation demands of the pharmaceutical and clinical research industry...
The pharma corridor between Hong Kong and Brussels Airport assures handling quality for temperature-sensitive pharmaceuticals.
On 23 June 2016, the decision was made on the European Union referendum for the United Kingdom to withdraw from the European Union.
A market report on the aspirin enteric-coated pharmaceutical industry outlines current trends and opportunities for growth from 2018 until 2023...
A study has found that an alarming number of families share leftover antibiotics between siblings, parents and others not even related to the family...
29 October 2018 | By Charles River
Timelines, budgets and regulatory constraints have grown alongside that of the Quality Control (QC) lab’s position in drug development. The main goal of the lab and more widely of the manufacturing industry is to increase safety for the end user and guarantee patients’ health...
The next five years will see game-changing improvements made in upstream, downstream and continuous bioprocessing, predicts one industry specialist...